Tumor Suppression
|
|
Growth control |
p53 dependent and independent call cycle arrest and apoptosis. ΔNp63 inhibition [4,5,11,12,13,31,32,33,34,42,43,55,79,80] |
Chromosomal stability |
Stabilization of miotic spindle, prevents aneuploidy [62] |
Ribosomal biogenesis |
Inhibition or rRNA processing and transcription [84,85,86,87] |
Oxidative stress |
Cellular protection from dysfunctional mitochondria [61] |
DNA damage |
Activation of ATM/ATR/CHK pathway, p53-dependent pathways of DNA repair [115,116] |
Contest Dependent
|
|
Autophagy |
Beclin-1 activation, dissipation of mitochondrion potential [60,123,124,125,126,127] |
Differentiation |
Inhibits angiogenesis in developing eye, protects from apoptosis in spermatogonia, allows extraembryonic endoderm migration [79,110,111,112,113,114,115,116,117] |
Tumor Promoter
|
|
Epithelial to mesechimal transition |
Slug stabilization [139] |
Modulation of tumor microenvironment |
Metallopeptidase-1 interaction [141] |
Survival of lymphoma, protease and bladder tumor cells |
Promotes prostate cancer in Pten mouse model and autophagy in lymphomas; promotes chemoresistance in bladder cancer [120,121,122,123,124,125,126,127,138,141,147] |
Anoikis protection, increased proliferation |
Inhibition of DAPK mediated cell death; activation focal adhesion kinase [67,160,161,162] |